Literature DB >> 12482477

Cellobiose and lactulose coupled with mannitol and determined using ion-exchange chromatography with pulsed amperometric detection, are reliable probes for investigation of intestinal permeability.

Maddalena Generoso1, Mario De Rosa, Roberto De Rosa, Laura De Magistris, Mario Secondulfo, Rafffaele Fiandra, Romano Carratù, Maria Cartenì.   

Abstract

Lactulose/mannitol and cellobiose/mannitol tests are currently used in the investigation of intestinal permeability (IP) in many gastrointestinal diseases. The aim of this study was to produce a good technique for the determination and comparison of the above-mentioned sugar probes to overcome the problem caused by the presence of significant glycosuria in patients affected by particular metabolic disorders such as diabetes mellitus. Tests were performed in 25 healthy volunteers, using either cellobiose (Ce) (5 g) and mannitol (Ma) (2 g), or lactulose (La) (5 g) and mannitol (2 g), given as oral isosmolar loads. Sugars were recovered in urine collected for 5 h. Analysis was carried out by using anion-exchange chromatography (AEC) with pulsed amperometric detection (PAD). Baseline separation of the above carbohydrates was achieved within 13 min by using a Carbopac PA-100 column and linear gradient elution. Carbohydrate quantification was performed by an internal standard method. The calibration curve for each sugar is linear to 40 mM. The limit of sugar detection is 0.01 mM. Recovery of sugar probes is between 98.2 and 100%. The %La, %Ce, %Ma in urine were evaluated and their ratios (Ce/Ma and La/Ma) were calculated. No significant difference in IP parameters were shown (La/Ma to Ce/Ma 0.018+/-0.014 vs. 0.012+/-0.007; the attendant probability of the null hypothesis being P=0.0714). Ce/Ma and/or La/Ma tests result similarly reliable in the clinical investigation of IP and the described new method is also helpful in urine even with high glucose concentration, without any interference.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12482477     DOI: 10.1016/s1570-0232(02)00766-3

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  11 in total

1.  Ultrastructural changes in enterocytes in subjects with Hashimoto's thyroiditis.

Authors:  F C Sasso; O Carbonara; R Torella; A Mezzogiorno; V Esposito; L Demagistris; M Secondulfo; R Carratu'; D Iafusco; M Cartenì
Journal:  Gut       Date:  2004-12       Impact factor: 23.059

2.  Nutrition, intestinal permeability, and blood ethanol levels are altered in patients with nonalcoholic fatty liver disease (NAFLD).

Authors:  Valentina Volynets; Markus A Küper; Stefan Strahl; Ina B Maier; Astrid Spruss; Sabine Wagnerberger; Alfred Königsrainer; Stephan C Bischoff; Ina Bergheim
Journal:  Dig Dis Sci       Date:  2012-03-17       Impact factor: 3.199

3.  Intestinal permeability in subjects from two different race groups with diverse stone-risk profiles.

Authors:  Takalani Theka; Allen Rodgers; Neil Ravenscroft; Sonja Lewandowski
Journal:  Urolithiasis       Date:  2013-01-22       Impact factor: 3.436

4.  A moderate weight reduction through dietary intervention decreases hepatic fat content in patients with non-alcoholic fatty liver disease (NAFLD): a pilot study.

Authors:  Valentina Volynets; Jürgen Machann; Markus A Küper; Ina B Maier; Astrid Spruss; Alfred Königsrainer; Stephan C Bischoff; Ina Bergheim
Journal:  Eur J Nutr       Date:  2012-04-28       Impact factor: 5.614

5.  Intestinal Dysbiosis and Yeast Isolation in Stool of Subjects with Autism Spectrum Disorders.

Authors:  Maria Rosaria Iovene; Francesca Bombace; Roberta Maresca; Anna Sapone; Patrizia Iardino; Annarita Picardi; Rosa Marotta; Chiara Schiraldi; Dario Siniscalco; Nicola Serra; Laura de Magistris; Carmela Bravaccio
Journal:  Mycopathologia       Date:  2016-09-21       Impact factor: 2.574

6.  Divergence of gut permeability and mucosal immune gene expression in two gluten-associated conditions: celiac disease and gluten sensitivity.

Authors:  Anna Sapone; Karen M Lammers; Vincenzo Casolaro; Marcella Cammarota; Maria Teresa Giuliano; Mario De Rosa; Rosita Stefanile; Giuseppe Mazzarella; Carlo Tolone; Maria Itria Russo; Pasquale Esposito; Franca Ferraraccio; Maria Cartenì; Gabriele Riegler; Laura de Magistris; Alessio Fasano
Journal:  BMC Med       Date:  2011-03-09       Impact factor: 8.775

7.  Circulating zonulin, a marker of intestinal permeability, is increased in association with obesity-associated insulin resistance.

Authors:  José María Moreno-Navarrete; Mònica Sabater; Francisco Ortega; Wifredo Ricart; José Manuel Fernández-Real
Journal:  PLoS One       Date:  2012-05-18       Impact factor: 3.240

8.  Modifying gut integrity and microbiome in children with severe acute malnutrition using legume-based feeds (MIMBLE): A pilot trial.

Authors:  Nuala Calder; Kevin Walsh; Peter Olupot-Olupot; Tonny Ssenyondo; Rita Muhindo; Ayub Mpoya; Jerusa Brignardello; Xuedan Wang; Eleanor McKay; Douglas Morrison; Elaine Holmes; Gary Frost; Kathryn Maitland
Journal:  Cell Rep Med       Date:  2021-05-18

9.  The effects of fluorouracil, epirubicin, and cyclophosphamide (FEC60) on the intestinal barrier function and gut peptides in breast cancer patients: an observational study.

Authors:  Francesco Russo; Michele Linsalata; Caterina Clemente; Benedetta D'Attoma; Antonella Orlando; Giovanna Campanella; Francesco Giotta; Giuseppe Riezzo
Journal:  BMC Cancer       Date:  2013-02-04       Impact factor: 4.430

10.  Antibodies against food antigens in patients with autistic spectrum disorders.

Authors:  Laura de Magistris; Annarita Picardi; Dario Siniscalco; Maria Pia Riccio; Anna Sapone; Rita Cariello; Salvatore Abbadessa; Nicola Medici; Karen M Lammers; Chiara Schiraldi; Patrizia Iardino; Rosa Marotta; Carlo Tolone; Alessio Fasano; Antonio Pascotto; Carmela Bravaccio
Journal:  Biomed Res Int       Date:  2013-08-01       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.